v3.26.1
Stock-based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Options Activity
The following table sets forth the summary of options activity, under the 2018 Plan and the 2021 Plan, for the year ended December 31, 2025:
(in thousands, except share-based data)Total OptionsWeighted- Average Exercise Price Per ShareWeighted- Average Remaining Contractual Term (In Years)Aggregate Intrinsic Value
Outstanding as of December 31, 202476 $20,245.33 
Granted2,352 28.06 
Forfeitures(4)17,647.50 
Outstanding as of December 31, 20252,424 $632.86 9.3$— 
Exercisable as of December 31, 20251,808 $842.10 9.2$— 
Vested and expected to vest as of December 31, 20252,424 $632.86 9.3$— 
Schedule of Restricted Stock Unit and Restricted Stock Award Activity
The following table sets forth the summary of RSU and RSA activity, under the Initial Plan, the 2018 Plan, the 2021 Plan, and the 2022 Plan, for the year ended December 31, 2025. RSAs were an immaterial portion of activity for the period:
SharesWeighted Average Grant Date Fair Value (i.e. Share Price)
Outstanding as of December 31, 2024332 $25,887.80 
Granted46,269 22.89 
Released(3,822)1,469.20 
Forfeited(175)6,450.86 
Outstanding as of December 31, 202542,604 $68.29 
Schedule of Stock-Based Compensation Expense
The following table sets forth the stock-based compensation under the Initial Plan, the 2018 Plan, the 2021 Plan, and the 2022 Plan by expense type:
Year Ended
December 31,
(in thousands)20252024
Research and development expenses$628 $793 
Selling, general and administrative expenses2,644 5,700 
Total$3,272 $6,493 
The following table sets forth the stock-based compensation under the Initial Plan, the 2018 Plan, the 2021 Plan, and the 2022 Plan by award type:
Year Ended
December 31,
(in thousands)20252024
Options$92 $289 
RSUs & RSAs3,180 6,204 
Total$3,272 $6,493